In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia.
Therefore, identification of individuals at risk of AF development/recurrence or its associated …

Natriuretic peptides (NPs) have become important diagnostic and prognostic biomarkers in
cardiovascular diseases, particularly in heart failure (HF). Diagnosis and management of …

Objective The association with B-type natriuretic peptide (BNP), disease progression and
outcomes in patients with atrial fibrillation (AF) has not been thoroughly investigated …

Objectives Atrial fibrillation (AF) is a significant public health issue due to its high prevalence
in the general population, and is associated with an increased risk of cardiovascular (CV) …

Studies on the association of elevated B‐type natriuretic peptide (BNP)/N‐terminal pro‐B‐
type natriuretic peptide (NT‐proBNP) level with adverse clinical outcomes have yielded …

Objectives Natriuretic peptides are an important prognostic marker in patients with heart
failure (HF). However, little is known regarding their prognostic significance in patients with …

Background Natriuretic peptides are routinely quantified to diagnose heart failure (HF). Their
concentrations are also elevated in atrial fibrillation (AF). To clarify their value in predicting …

Background Patients with heart failure (HF) and atrial fibrillation (AF) have higher circulating
levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide) than HF patients without AF …

Background—Atrial fibrillation (AF), the most common cardiac rhythm abnormality, is
associated with significant morbidity, mortality, and healthcare expenditures. Elevated B …

Aims Heart failure (HF) and atrial fibrillation (AF) frequently coexist and are both associated
with increased levels of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP). It is known …